CLDN4 and breast carcinoma: Because both LXRβ and LXRβS432 were essential for the CLDN4-accelerated cell proliferation and tumor growth in breast cancer cells, the LXRβ- and LXRβS432-dependent CLDN4-controlling gene products would be critical to promote breast cancer progression.